Blood–brain barrier transport of pramipexole, a dopamine D2 agonist
- 1 April 2007
- journal article
- Published by Elsevier in Life Sciences
- Vol. 80 (17) , 1564-1571
- https://doi.org/10.1016/j.lfs.2007.01.035
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- In Vivo Blood-Brain Barrier Transport of Oxycodone in the Rat: Indications for Active Influx and Implications for Pharmacokinetics/PharmacodynamicsDrug Metabolism and Disposition, 2006
- TRANSPORT OF THE DOPAMINE D2 AGONIST PRAMIPEXOLE BY RAT ORGANIC CATION TRANSPORTERS OCT1 AND OCT2 IN KIDNEYDrug Metabolism and Disposition, 2005
- SATURABLE DISTRIBUTION OF TACRINE INTO THE STRIATAL EXTRACELLULAR FLUID OF THE RAT: EVIDENCE OF INVOLVEMENT OF MULTIPLE ORGANIC CATION TRANSPORTERS IN THE TRANSPORTDrug Metabolism and Disposition, 2005
- INFLUX AND EFFLUX TRANSPORT OF H1-ANTAGONIST EPINASTINE ACROSS THE BLOOD-BRAIN BARRIERDrug Metabolism and Disposition, 2004
- Pharmacological and Physiological Functions of the Polyspecific Organic Cation Transporters: OCT1, 2, and 3 (SLC22A1-3)The Journal of Pharmacology and Experimental Therapeutics, 2004
- Organic cation transportersPublished by Springer Nature ,2003
- Organic cation transporter mRNA and function in the rat superior cervical ganglionThe Journal of Physiology, 2002
- Ventricular Choline TransportPublished by Elsevier ,2001
- Pramipexole binding and activation of cloned and expressed dopamine D2, D3 and D4 receptorsEuropean Journal of Pharmacology: Molecular Pharmacology, 1995
- Transport Mechanism of an H1-Antagonist at the Blood-Brain Barrier: Transport Mechanism of Mepyramine Using the Carotid Injection Technique.Biological & Pharmaceutical Bulletin, 1994